Debt-to-equity improved to 0.29 in Q2 2026 from 0.69 in Q3 2024, with total debt down to $136.3M and equity up 40% to $462.4M.
UFP Technologies, Inc. (UFPT) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 234.89M | 201M | 194.94M | 144.63M | 116.35M | 87.32M | 71.86M | 53.25M | 55.63M | 75.07M | 69.85M | 63.6M | 68.41M | 68.83M | 64.49M | 58.04M | 50.77M | 38.75M | 29.64M | 28.58M | 20.37M | 23.58M | 18.56M | 15.84M | 15.12M | 17.2M | 18.51M | 15.8M | 13.2M | 9.8M | 8.9M |
| Cash & Short-Term Investments | 9.04M | 20.3M | 13.45M | 5.26M | 4.45M | 11.12M | 24.23M | 3.74M | 3.24M | 37.98M | 31.36M | 29.8M | 34.05M | 37.3M | 33.48M | 29.85M | 24.43M | 15M | 6.73M | 9.06M | 1.02M | 265.35K | 317.95K | 310.14K | 25.82K | 26.77K | 94.05K | 300K | 500K | 200K | 100K |
| Cash Only | 9.04M | 20.3M | 13.45M | 5.26M | 4.45M | 11.12M | 24.23M | 3.74M | 3.24M | 37.98M | 31.36M | 29.8M | 34.05M | 37.3M | 33.48M | 29.85M | 24.43M | 15M | 6.73M | 9.06M | 1.02M | 265.35K | 317.95K | 310.14K | 25.82K | 26.77K | 94.05K | 300K | 500K | 200K | 100K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 117.37M | 88.22M | 89.66M | 65.75M | 55.12M | 39.38M | 26.43M | 28.93M | 28.32M | 21.38M | 21.25M | 17.48M | 16.47M | 17.03M | 19.55M | 16.71M | 16.05M | 14.22M | 12.75M | 11.8M | 11.63M | 15.3M | 11.82M | 9.56M | 8.54M | 9.45M | 10.69M | 9.7M | 7.9M | 6.4M | 5.6M |
| Days Sales Outstanding | 57.08 | 53.42 | 64.88 | 59.98 | 56.86 | 69.67 | 53.78 | 53.22 | 54.28 | 52.79 | 53.07 | 45.95 | 43.15 | 44.65 | 54.48 | 47.92 | 48.5 | 52.3 | 42.31 | 46 | 45.27 | 66.51 | 62.86 | 57.29 | 50.96 | 56.04 | 52.39 | 60.21 | 61.09 | 51.34 | 51.88 |
| Inventory | 100.09M | 86.86M | 87.54M | 70.19M | 53.54M | 33.44M | 18.64M | 18.28M | 19.58M | 12.86M | 14.15M | 14.2M | 12.89M | 11.05M | 9.7M | 9.76M | 8.04M | 7.65M | 8.15M | 5.88M | 5.93M | 6.44M | 5.24M | 4.41M | 4.69M | 5.2M | 6.78M | 5.2M | 4.1M | 3.1M | 2.6M |
| Days Inventory Outstanding | 74.16 | 73.32 | 89.32 | 89 | 74.15 | 78.63 | 50.52 | 46.19 | 50.27 | 41.79 | 46.33 | 51.12 | 45.94 | 40.91 | 38.14 | 39.14 | 34.08 | 38.49 | 36.53 | 30.3 | 29.05 | 33.9 | 34.97 | 32.1 | 34.9 | 37.5 | 46.01 | 45.63 | 46.48 | 36.03 | 34.01 |
| Other Current Assets | 8.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.29M | 1.02M | 807K | 871K | 1.14M | 2.65M | 1.12M | 1.17M | 1.21M | 1.41M | 1.49M | 1.02M | 1.03M | 781.99K | 481.05K | 1.06M | 1.36M | 0 | 946K | 600K | 700K | 100K | 600K |
| Total Non-Current Assets | 447.02M | 464.73M | 434.05M | 259.5M | 261.85M | 246.81M | 131.34M | 135.51M | 133.97M | 63.13M | 58.09M | 56.35M | 45.28M | 36.19M | 34.12M | 21.68M | 21.04M | 20.7M | 19.08M | 16.98M | 18.66M | 20.42M | 21.07M | 20.91M | 20.26M | 20.9M | 21.84M | 16.1M | 16.7M | 15.4M | 14M |
| Property, Plant & Equipment | 76.92M | 97.99M | 86.71M | 75.72M | 71.22M | 65.89M | 55.91M | 59.77M | 57.67M | 53.65M | 48.52M | 46.55M | 34.84M | 25.51M | 23.32M | 13.35M | 12.58M | 12.22M | 11.75M | 9.49M | 10.14M | 10.97M | 11.38M | 11.47M | 11.21M | 12.05M | 12.45M | 10.6M | 10.9M | 11.2M | 9.7M |
| Fixed Asset Turnover | 6.87x | 6.15x | 5.82x | 5.28x | 4.97x | 3.13x | 3.21x | 3.32x | 3.30x | 2.76x | 3.01x | 2.98x | 4.00x | 5.46x | 5.62x | 9.53x | 9.60x | 8.12x | 9.36x | 9.86x | 9.25x | 7.65x | 6.03x | 5.31x | 5.46x | 5.11x | 5.98x | 5.55x | 4.33x | 4.06x | 4.06x |
| Goodwill | 196.44M | 197.4M | 189.66M | 113.26M | 113.03M | 107.91M | 51.84M | 51.84M | 51.84M | 7.32M | 7.32M | 7.32M | 7.32M | 7.32M | 7.04M | 6.48M | 6.48M | 6.48M | 6.48M | 6.48M | 6.48M | 0 | 0 | 0 | 0 | 6.41M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 135.25M | 140.85M | 144.25M | 64.12M | 68.36M | 67.58M | 19.72M | 20.98M | 22.23M | 0 | 318K | 636K | 953K | 1.35M | 2.08M | 398.5K | 593.83K | 817.74K | 0 | 0 | 0 | 6.48M | 6.48M | 6.48M | 6.48M | 0 | 6.72M | 4.5M | 4.7M | 2.5M | 2.6M |
| Long-Term Investments | 27.42M | 6.93M | 6.81M | 0 | 0 | 0 | 0 | 0 | -4.13M | -9.76M | -11.1M | -10.84M | -9.42M | -9.89M | -1.13B | -1.17B | -1.21B | -1.42B | -1.49B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 31.74M | 10.91M | 6.62M | 5.79M | 7.78M | 5.43M | 3.88M | 2.92M | 2.23M | 9.48M | 9.57M | 9.79M | 10.43M | 10.68M | 10.8M | 1.45M | 1.39M | 8.48M | 845.35K | 816.26K | 657.25K | 471.65K | 504.69K | 574.63K | 925.85K | 857.51K | 2.66M | 1M | 1.1M | 1.7M | 1.7M |
| Total Assets | 681.91M | 665.74M | 629M | 404.14M | 378.19M | 334.13M | 203.2M | 188.76M | 189.6M | 138.21M | 127.93M | 119.95M | 113.69M | 105.02M | 98.62M | 79.72M | 71.81M | 59.45M | 48.72M | 45.55M | 39.04M | 44M | 39.63M | 36.75M | 35.38M | 38.1M | 40.35M | 31.9M | 29.9M | 25.2M | 22.9M |
| Asset Turnover | 0.94x | 0.91x | 0.80x | 0.99x | 0.94x | 0.62x | 0.88x | 1.05x | 1.00x | 1.07x | 1.14x | 1.16x | 1.23x | 1.33x | 1.33x | 1.60x | 1.68x | 1.67x | 2.26x | 2.05x | 2.40x | 1.91x | 1.73x | 1.66x | 1.73x | 1.62x | 1.85x | 1.84x | 1.58x | 1.81x | 1.72x |
| Asset Growth % | 20.51% | 5.84% | 55.64% | 6.86% | 13.19% | 64.43% | 7.65% | -0.44% | 37.18% | 8.03% | 6.66% | 5.51% | 8.26% | 6.49% | 23.7% | 11.02% | 20.78% | 22.02% | 6.96% | 16.69% | -11.28% | 11.02% | 7.85% | 3.86% | -7.14% | -5.58% | 26.5% | 6.69% | 18.65% | 10.04% | 10.1% |
| Total Current Liabilities | 78.3M | 74.86M | 76.3M | 58.21M | 55.96M | 38.78M | 15.14M | 16.78M | 20.66M | 9.94M | 9.56M | 10.98M | 11.61M | 12.32M | 13.23M | 9.47M | 12.5M | 11.05M | 10.95M | 13.62M | 12.14M | 20.26M | 17.13M | 14.63M | 13.58M | 16.22M | 14.37M | 12.2M | 11.1M | 7.3M | 6.4M |
| Accounts Payable | 32.96M | 24.29M | 24.27M | 22.29M | 19.96M | 10.61M | 4.12M | 4.58M | 6.84M | 4.18M | 4M | 4.6M | 5.4M | 3.08M | 4.09M | 3.34M | 5.17M | 4.27M | 3.3M | 5.69M | 4.62M | 6.06M | 3.67M | 2.63M | 2.6M | 3.81M | 4.44M | 2.4M | 2.6M | 1.5M | 2.2M |
| Days Payables Outstanding | 23.26 | 20.5 | 24.76 | 28.26 | 27.65 | 24.95 | 11.17 | 11.57 | 17.55 | 13.58 | 13.1 | 16.55 | 19.24 | 11.41 | 16.08 | 13.41 | 21.9 | 21.51 | 14.8 | 29.36 | 22.63 | 31.9 | 24.48 | 19.15 | 19.31 | 27.44 | 30.13 | 21.06 | 29.47 | 17.44 | 28.78 |
| Short-Term Debt | 12.5M | 12.5M | 12.5M | 4M | 4M | 4M | 0 | 0 | 2.86M | 0 | 856K | 1.01M | 993K | 976K | 1.55M | 580.66K | 654.33K | 623.01K | 716.7K | 1.42M | 1.77M | 9.72M | 9.48M | 8.17M | 7.17M | 7.39M | 6.08M | 6M | 5.2M | 3.5M | 2.4M |
| Deferred Revenue (Current) | 18.5M | 4.24M | 4.67M | 6.62M | 4.68M | 4.25M | 1.89M | 2.57M | 2.51M | 297K | 0 | 0 | 0 | 1.43M | 0 | 4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 37K | 11.71M | 11.29M | 8.74M | 7.95M | 11.2M | 5.71M | 6.31M | 2.63M | 3.86M | 0 | 1.42M | 425K | 5.7M | 5.28M | 1.54M | 3.04M | 0 | 2.42M | 2.83M | 2.13M | 1.99M | 1.56M | 0 | 0 | 0 | 3.85M | 3.8M | 3.3M | 2.3M | 1.8M |
| Current Ratio | 3.00x | 2.68x | 2.56x | 2.48x | 2.08x | 2.25x | 4.75x | 3.17x | 2.69x | 7.55x | 7.31x | 5.79x | 5.89x | 5.59x | 4.87x | 6.13x | 4.06x | 3.51x | 2.71x | 2.10x | 1.68x | 1.16x | 1.08x | 1.08x | 1.11x | 1.06x | 1.29x | 1.30x | 1.19x | 1.34x | 1.39x |
| Quick Ratio | 1.72x | 1.52x | 1.41x | 1.28x | 1.12x | 1.39x | 3.52x | 2.08x | 1.75x | 6.26x | 5.83x | 4.50x | 4.78x | 4.69x | 4.14x | 5.10x | 3.42x | 2.81x | 1.96x | 1.67x | 1.19x | 0.85x | 0.78x | 0.78x | 0.77x | 0.74x | 0.82x | 0.87x | 0.82x | 0.92x | 0.98x |
| Cash Conversion Cycle | 107.99 | 106.24 | 129.43 | 120.73 | 103.37 | 123.35 | 93.13 | 87.84 | 86.99 | 80.99 | 86.3 | 80.52 | 69.86 | 74.15 | 76.54 | 73.65 | 60.68 | 69.28 | 64.03 | 46.94 | 51.69 | 68.5 | 73.35 | 70.24 | 66.55 | 66.09 | 68.28 | 84.78 | 78.09 | 69.94 | 57.11 |
| Total Non-Current Liabilities | 141.18M | 167M | 209.94M | 59.84M | 84.69M | 100.9M | 11.17M | 9.98M | 28.48M | 4.55M | 5.33M | 5.39M | 7.08M | 7.11M | 12.13M | 8.27M | 9.08M | 9.4M | 5.88M | 7.1M | 7.66M | 8.35M | 8.28M | 8.98M | 7.75M | 7.73M | 8.45M | 3.5M | 2.9M | 3.8M | 3.8M |
| Long-Term Debt | 104.81M | 122.95M | 176.88M | 28M | 51M | 71M | 0 | 0 | 22.29M | 0 | 0 | 859K | 1.87M | 2.87M | 8.31M | 5.64M | 6.85M | 7.5M | 3.94M | 4.66M | 4.6M | 5.29M | 5.85M | 6.22M | 5.87M | 6.68M | 7.59M | 2.7M | 2.1M | 3.2M | 3.2M |
| Capital Lease Obligations | 56.16M | 13.99M | 12.43M | 10.81M | 10.85M | 7.12M | 1.04M | 1.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 909.9K | 1.61M | 2.32M | 2.36M | 1.65M | 1.9M | 984.9K | 149.23K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 52.87M | 19.87M | 3.3M | 428K | 448K | 3.26M | 5.06M | 4.92M | 4.13M | 2.44M | 3.46M | 2.88M | 3.59M | 2.44M | 1.59M | 1.29M | 880.77K | 776.88K | 113.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.39M | 10.18M | 17.34M | 20.59M | 22.39M | 19.52M | 5.08M | 3.12M | 6.2M | 2.11M | 5.33M | 4.54M | 1.62M | 1.8M | 3.81M | 1.34M | 1.35M | 1.12M | 913.64K | 832.14K | 737.58K | 695.78K | 780.5K | 856.69K | 900.31K | 898.74K | 861.64K | 800K | 800K | 600K | 600K |
| Total Liabilities | 219.48M | 241.86M | 286.24M | 118.05M | 140.65M | 139.69M | 26.31M | 26.77M | 49.14M | 14.49M | 14.88M | 16.38M | 18.7M | 19.43M | 25.36M | 17.74M | 21.58M | 20.45M | 16.83M | 20.73M | 19.8M | 28.6M | 25.41M | 23.6M | 21.33M | 23.95M | 22.82M | 15.7M | 14M | 11.1M | 10.2M |
| Total Debt | 136.34M | 154.48M | 206.03M | 46.04M | 68.37M | 84.36M | 2.21M | 3.09M | 25.14M | 0 | 856K | 1.87M | 2.87M | 3.84M | 9.86M | 6.22M | 7.5M | 8.13M | 6.27M | 7.69M | 8.69M | 17.37M | 16.98M | 16.29M | 14.02M | 14.22M | 13.67M | 8.7M | 7.3M | 6.7M | 5.6M |
| Net Debt | 127.29M | 134.18M | 192.58M | 40.77M | 63.92M | 73.24M | -22.03M | -653K | 21.91M | -37.98M | -30.5M | -27.93M | -31.19M | -33.46M | -23.62M | -23.63M | -16.93M | -6.87M | -458.01K | -1.37M | 7.67M | 17.1M | 16.66M | 15.98M | 13.99M | 14.2M | 13.58M | 8.4M | 6.8M | 6.5M | 5.5M |
| Debt / Equity | 0.29x | 0.36x | 0.60x | 0.16x | 0.29x | 0.43x | 0.01x | 0.02x | 0.18x | - | 0.01x | 0.02x | 0.03x | 0.04x | 0.13x | 0.10x | 0.15x | 0.21x | 0.20x | 0.31x | 0.45x | 1.13x | 1.19x | 1.24x | 1.00x | 1.00x | 0.78x | 0.54x | 0.46x | 0.48x | 0.44x |
| Debt / EBITDA | 1.18x | 1.33x | 2.15x | 0.67x | 1.02x | 2.85x | 0.09x | 0.09x | 0.92x | - | 0.05x | 0.11x | 0.18x | 0.18x | 0.50x | 0.34x | 0.43x | 0.73x | 0.55x | 0.76x | 1.07x | 3.40x | 3.66x | 13.60x | 4.45x | - | 2.11x | 1.55x | 1.43x | 1.40x | 1.51x |
| Net Debt / EBITDA | 1.10x | 1.16x | 2.01x | 0.59x | 0.95x | 2.47x | -0.88x | -0.02x | 0.80x | -2.19x | -1.71x | -1.69x | -1.96x | -1.56x | -1.21x | -1.28x | -0.97x | -0.62x | -0.04x | -0.14x | 0.95x | 3.35x | 3.59x | 13.34x | 4.44x | - | 2.10x | 1.50x | 1.33x | 1.35x | 1.49x |
| Interest Coverage | 12.41x | 9.42x | 10.06x | 15.79x | 20.08x | 544.72x | 197.18x | 36.08x | 15.65x | 235.26x | 179.51x | 498.00x | 110.36x | 84.92x | 181.13x | 584.81x | 124.46x | 37.02x | 29.14x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 462.43M | 423.88M | 342.76M | 286.09M | 237.54M | 194.45M | 176.89M | 161.99M | 140.46M | 123.71M | 113.05M | 102.98M | 94.99M | 85.59M | 73.26M | 61.98M | 50.23M | 39.48M | 31.89M | 24.83M | 19.24M | 15.4M | 14.22M | 13.15M | 14.05M | 14.15M | 17.53M | 16.2M | 15.9M | 14.1M | 12.7M |
| Equity Growth % | 88.02% | 23.67% | 19.81% | 20.44% | 22.17% | 9.92% | 9.2% | 15.33% | 13.54% | 9.43% | 9.78% | 8.41% | 10.98% | 16.83% | 18.19% | 23.41% | 27.23% | 23.79% | 28.45% | 29.03% | 24.98% | 8.26% | 8.17% | -6.43% | -0.73% | -19.24% | 8.19% | 1.89% | 12.77% | 11.02% | 11.4% |
| Book Value per Share | 59.32 | 54.32 | 44.03 | 37.15 | 31.00 | 25.53 | 23.38 | 21.55 | 18.90 | 16.86 | 15.54 | 14.27 | 13.24 | 12.05 | 10.42 | 8.86 | 7.44 | 6.27 | 5.09 | 4.24 | 3.45 | 2.93 | 2.85 | 2.93 | 3.24 | 3.33 | 4.00 | 3.31 | 3.29 | 2.90 | 2.54 |
| Total Shareholders' Equity | 462.43M | 423.88M | 342.76M | 286.09M | 237.54M | 194.45M | 176.89M | 161.99M | 140.46M | 123.71M | 113.05M | 103.57M | 94.99M | 85.59M | 73.26M | 61.31M | 49.7M | 39.01M | 31.37M | 24.24M | 18.62M | 14.76M | 13.79M | 12.69M | 14.05M | 14.15M | 17.53M | 16.2M | 15.9M | 14.1M | 12.7M |
| Common Stock | 77K | 77K | 77K | 76K | 76K | 75K | 75K | 74K | 74K | 73K | 72K | 72K | 71K | 69K | 67.5K | 65.55K | 63.39K | 59.45K | 56.67K | 53.75K | 51.57K | 48.28K | 46.79K | 45.2K | 43.66K | 42.17K | 43.88K | 0 | 0 | 0 | 0 |
| Retained Earnings | 413.16M | 374.81M | 306.5M | 247.52M | 202.6M | 160.81M | 144.92M | 131.55M | 111.8M | 97.56M | 88.35M | 80.38M | 72.79M | 65.23M | 53.95M | 43.06M | 32.71M | 23.47M | 17.54M | 12.42M | 8.26M | 5.75M | 5.09M | 4.22M | 5.73M | 5.97M | 9.01M | 7.9M | 6.2M | 4.6M | 3.3M |
| Treasury Stock | -587K | -587K | -587K | -587K | -587K | -587K | -587K | -587K | -587K | -587K | -587K | -587K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.51M | 3.71M | -4.17M | 268K | -610K | 0 | 0 | 0 | -54.11M | -53.06M | -48.29M | -44.01M | -40.98M | -39.07M | -36.25M | -34.29M | -32.88M | -31.36M | -28.91M | -28.78M | -27.08M | -25.75M | -23.28M | -21.7M | -18M | -16.33M | -13.46M | -11.1M | -9.1M | -8.9M | -7.5M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -587K | 0 | 0 | 0 | 674.25K | 525.99K | 470.56K | 523K | 583.53K | 616.16K | 633.85K | 433.81K | 455.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying UFPT stock.
As of 2025, UFP Technologies, Inc. (UFPT) had total assets of $665.7M including $201.0M in current assets.
UFP Technologies, Inc. (UFPT) carries total debt of $154.5M, offset by $20.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
UFP Technologies, Inc. (UFPT) has total shareholders' equity (book value) of $423.9M ($54.32 book value per share). Book value represents the net worth of the company belonging to common stock holders.
UFP Technologies, Inc. (UFPT) reported a current ratio of 2.68x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Customer concentration and EPS miss
Metrics are mathematically derived from official filings.
Leverage Decline Signals Strengthening Balance Sheet
UFPT's debt-to-equity ratio fell from 0.69 in Q3 2024 to 0.29 in Q2 2026, while equity grew 40% to $462.4M, indicating a progressively stronger balance sheet, as per recent quarterly filings.
The sequential decline in total liabilities from $309.4M in Q3 2024 to $219.5M in Q2 2026, coupled with a rise in equity, suggests a deliberate deleveraging trend. This appears driven by retained earnings accumulation and possibly debt repayment, which may indicate improved financial flexibility for future acquisitions or investments. The trajectory implies a strengthening balance sheet that could support continued growth initiatives.
Debt Reduction Enhances Financial Flexibility
Total debt dropped from $227.9M in Q3 2024 to $136.3M in Q2 2026, reducing D/E to 0.29, as reported in the latest balance sheet data, suggesting a strategic shift toward lower leverage.
The substantial reduction in debt, particularly the $48M jump in Q3 2024 likely from an acquisition, has been steadily paid down. This deleveraging appears deliberate, possibly to lower interest costs and improve creditworthiness. With D/E now at 0.29, UFPT appears well-positioned to finance future M&A without straining its balance sheet, though investors should monitor whether this reflects a strategic choice or a response to cash flow constraints.
Asset Mix Reflects Medical Pivot
Goodwill and intangibles rose to $196.4M in Q2 2026, representing 29% of total assets, while PPE net declined to $76.9M, indicating an asset-light model with acquisition-driven growth, as per balance sheet data.
The increase in goodwill from $115.6M in Q2 2024 to $196.4M in Q2 2026 aligns with the company's acquisition strategy, particularly the $191.8M deployment in Q3 2024. This suggests that growth is increasingly reliant on acquired capabilities rather than organic capital expenditure. The relatively low PPE net (11% of assets) underscores a low capital intensity, but the rising goodwill raises impairment risk if acquired businesses underperform, warranting monitoring of segment performance.
Retained Earnings Drive Equity Growth
Equity expanded to $462.4M in Q2 2026 from $295.0M in Q1 2024, with retained earnings climbing to $413.2M, reflecting strong profit retention and no dividend payouts, as per reported figures.
The consistent rise in retained earnings, up $153M over the period, indicates that UFPT is reinvesting profits into the business rather than distributing them. This supports the company's growth strategy, but also implies that shareholders rely on capital appreciation. The absence of buybacks or dividends, as noted in cash flow analysis, suggests management prioritizes reinvestment, which may be appropriate given the acquisition-led growth model.
Liquidity Buffer Remains Solid
Current ratio improved to 3.00 in Q2 2026 from 2.56 in Q4 2024, while cash dipped to $9.0M, indicating adequate short-term coverage despite a low cash balance, as per balance sheet data.
The current ratio above 3.0 suggests that current assets comfortably cover current liabilities, providing a buffer against operational shocks. However, the cash position of $9.0M is relatively thin, which may indicate reliance on operating cash flow or credit lines for near-term needs. Given the company's low debt and strong cash flow generation, this appears manageable, but investors should monitor cash levels if acquisition activity accelerates.
Goodwill Impairment Risk Lurks
Goodwill of $196.4M, nearly 29% of total assets, stems from acquisitions and could be impaired if acquired businesses underperform, potentially distorting reported equity, as per balance sheet data.
The significant goodwill balance, accumulated through acquisitions, represents a risk to reported equity if future cash flows from these businesses fail to meet expectations. While no impairment has been recorded, the concentration of goodwill suggests that any downturn in the medical segment or integration issues could lead to write-downs, reducing equity and potentially impacting leverage ratios. This warrants close monitoring of segment performance and acquisition integration.